Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease
Authors:
- Krishna J. Rocha‐SinghKRKrishna J. Rocha‐Singh
- Michael R. JaffMJMichael R. Jaff
- Gary AnselGAGary Ansel
- Inc. On Behalf Of Viva PhysiciansIPInc. On Behalf Of Viva Physicians
- 20 April 2007
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 69 (6) , 910-919
Abstract
Objective: This analysis proposes safety and performance goals for prospective single‐arm trials of bare nitinol stents to treat patients with debilitating claudication associated with femoropopliteal (FP) atherosclerotic lesions. Background: To date there have been no analyses of clinical trials data to set efficacy and safety benchmarks for new bare nitinol stents in the treatment of claudication from FP disease. Industry has been reluctant to sponsor studies of nitinol stents due to logistical barriers. Methods: VIVA Physician's, Inc. (VPI) analyzed subject‐level data from the PTA control arm of three randomized FDA device trials conducted by industry. Subjects with Rutherford category 2‐4 claudication and FP lesion lengths 4–15 cm with 12 month duplex ultrasound (DUS) assessment were identified. These data were combined with the results of a survey of the medical literature (1990–2006) for similar subjects. Results: Analysis of the industry derived control arm PTA data identified 116 patients (mean lesion length 8.7 cm) with a 12 month DUS defined FP patency of 28%. A similar cohort of 191 patients was identified from the medical literature in which the 12‐month vessel patency equaled 37%; from these combined patient cohorts, expected vessel patency for PTA was estimated to equal 33%. Conclusion: Based on the PTA performance efficacy rate of 33% derived from industry clinical trial data and the medical literature, and the requirement that the bare nitinol stent 12‐month efficacy performance goal be set to equal twice this rate, the patency efficacy goal equals 66%. Additional information is provided on safety and other reporting standards and stent integrity evaluation for bare metal stents.Keywords
This publication has 19 references indexed in Scilit:
- Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral ArteryNew England Journal of Medicine, 2006
- ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary A Collaborative Report From the American Association for Vascular Surgery/Society for Vascular Surgery,⁎⁎AAVS/SVS when Guideline initiated, now merged into SVSSociety for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease)JACC, 2006
- Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: A randomized trialCatheterization and Cardiovascular Interventions, 2006
- Prevalence and clinical impact of stent fractures after femoropopliteal stentingJACC, 2005
- Angioplasty or Bypass for Superficial Femoral Artery Disease? A Randomised Controlled TrialEuropean Journal of Vascular and Endovascular Surgery, 2004
- Sirolimus-Eluting Stents for the Treatment of Obstructive Superficial Femoral Artery DiseaseCirculation, 2002
- Approximate Is Better than "Exact" for Interval Estimation of Binomial ProportionsThe American Statistician, 1998
- Comparison of Balloon Angioplasty and Simpson Atherectomy for Lesions in the Femoropopliteal Artery: Angiographic and Clinical Results of a Prospective Randomized TrialJournal of Vascular and Interventional Radiology, 1996
- Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudicationEuropean Journal of Vascular and Endovascular Surgery, 1996
- Clinical Trials for ClaudicationCirculation, 1995